KEY POINTS
  • Pfizer is seeking permission from the FDA to store its Covid-19 vaccine for two weeks at temperatures commonly found in pharmaceutical freezers and refrigerators.
  • If the FDA grants Pfizer's request, it could make it easier to distribute the vaccine across the U.S. at a time when the pace of inoculations has been slow.

In this article

A picture taken on January 15, 2021, shows a pharmacist holding with gloved hands a phial of the undiluted Pfizer-BioNTech vaccine for Covid-19, stored at -70 ° in a super freezer of the hospital of Le Mans, northwestern France as the country carry on a vaccination campaign to fight against the spread of the novel coronavirus.

Pfizer said Friday it is seeking permission from the Food and Drug Administration to store its Covid-19 vaccine for two weeks at temperatures commonly found in pharmaceutical freezers and refrigerators.

The vaccine, which was developed with German drugmaker BioNTech, currently needs to be stored in ultra-cold freezers that keep it between minus 112 and minus 76 degrees Fahrenheit, according to the FDA. Pfizer said it submitted new data to the U.S. agency that shows the vaccine is stable between minus 13 and 5 degrees Fahrenheit.

In this article